Abbott says gets FDA nod for lower-strength HIV pill

Abbott says gets FDA nod for lower-strength HIV pill
(Reuters) - Abbott Laboratories said it received approvalfrom U.S. health regulators for a new lower-strength tabletformulation of its HIV drug, Kaletra, which is also marketed asAluvia in developing countries.
The lower-strength Kaletra tablets, which will be used totreat children, would be available in the United States thismonth.
(Reporting by Aniruddha Basu in Bangalore; Editing byPratish Narayanan)